GoodRx Holdings (GDRX) was rated a "new sector weight" by a sell-side firm Friday. Let's check out the charts and indicators to see if this coverage will help the stock.
In the daily bar chart of GDRX, below, we can see the punishing slide in price from October to June. The shares have traded sideways since June with a temporary rally in August. GDRX has been unable to make a higher low as a stepping stone towards a price increase. The slope of the 50-day moving average line is neutral but the 200-day line remains negative.
The On-Balance-Volume (OBV) line shows a decline into early August and only modest improvement since. The Moving Average Convergence Divergence (MACD) oscillator has been hugging the zero line and thus not showing us any trend strength.
In the weekly Japanese candlestick chart of GDRX, below, we see a bearish picture with a noticeable upper shadow in early August telling us that traders were rejecting the highs.
The weekly OBV line is not promising while the MACD oscillator has been in sell territory since late 2021.
In this daily Point and Figure chart of GDRX, below, we can see an upside price target in the $8 area. A trade at $6.07 could weaken this chart.
In this weekly Point and Figure chart of GDRX, below, we can see a downside price target around $2 or so.
Bottom-line strategy: Shares of GDRX are looking like they will be priced like some generic drugs -- lower and lower. Avoid the long side of GDRX.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.
